Skip to content

4/AAccepted Mar 24, 6:45 PM ET

Yeramian Patrick D 4/A

AMLXAmylyx Pharmaceuticals, Inc.

Accepted (ET)

6:45 PM

Mar 24, 2023

Filed

Mar 24, 2023

Documents

2

Size

28.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.